Personalised analytics for rare disease diagnostics
Genome sequencing is being widely adopted for diagnosis of genetic diseases, but identifying the causal variants remains challenging. Here, the authors introduce a tool that incorporates tissue-specific gene expression data into predicting variant pathogenicity, improving accuracy.
Enregistré dans:
Auteurs principaux: | Denise Anderson, Gareth Baynam, Jenefer M. Blackwell, Timo Lassmann |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/63acb38dd4c14d16b5884b95ac16f5b9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening
par: Lorna J. Hale, et autres
Publié: (2018) -
Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
par: Kartik Kumar, et autres
Publié: (2021) -
Community capital and the role of the state: an empowering approach to personalisation
par: Patricia Jones
Publié: (2013) -
The effect of protein mutations on drug binding suggests ensuing personalised drug selection
par: Shunzhou Wan, et autres
Publié: (2021) -
Possibilities for personalised medicine in rheumatoid arthritis: hype or hope
par: Pascal Hendrik Pieter de Jong, et autres
Publié: (2021)